Sign Out
Use in pregnancy is not recommended unless clearly needed. Pregnancy category: B Discontinuation of treatment in a pregnant woman with primary systemic carnitine deficiency may carry serious consequences; the risk of stopping treatment may outweigh the theoretical risks to the fetus. Animal studies showed no evidence of impaired fertility or fetal harm, however at 600 mg/kg daily there was a statistically insignificant increase in post implantation losses. There are no controlled data in human pregnancy.
In use during breastfeeding, the risks to the infant from excess carnitine intake should be weighed against the benefits of supplementation to the mother. L-Carnitine (Carnicor) concentration in milk is increased in dairy cows after exogenous administration. There is no available data on L-carnitine excretion in human milk.
Continue with Google